ImmuCell CorporationICCCNASDAQ
Loading
Price to Sales HistoryFair Value
Percentile Rank14
3Y CAGR-7.6%
5Y CAGR-6.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-7.6%/yr
vs -7.8%/yr prior
5Y CAGR
-6.4%/yr
Consistent
Acceleration
+0.2pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.01 | +26.5% |
| 2024 | 1.59 | -29.2% |
| 2023 | 2.24 | -11.8% |
| 2022 | 2.54 | -19.4% |
| 2021 | 3.16 | +12.8% |
| 2020 | 2.80 | +9.3% |
| 2019 | 2.56 | -27.3% |
| 2018 | 3.52 | -15.6% |
| 2017 | 4.17 | +58.3% |
| 2016 | 2.63 | - |